Northern Trust’s Bristol-Myers Squibb BMY Stock Holding History

Northern Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.5B	Buy	24,758,771 +163,677	+0.7%	+$9.54M	0.2%	90
2025 Q4	$1.33B	Sell	24,595,094 -26,549	-0.1%	-$1.28M	0.17%	107
2025 Q3	$1.11B	Sell	24,621,643 -257,367	-1%	-$12M	0.14%	126
2025 Q2	$1.15B	Sell	24,879,010 -1,095,494	-4%	-$53.8M	0.16%	118
2025 Q1	$1.58B	Buy	25,974,504 +1,316,144	+5%	+$76.7M	0.24%	80
2024 Q4	$1.39B	Buy	24,658,360 +3,431,248	+16%	+$192M	0.2%	90
2024 Q3	$1.1B	Sell	21,227,112 -538,942	-2%	-$25.3M	0.18%	106
2024 Q2	$904M	Sell	21,766,054 -1,236,306	-5%	-$55.3M	0.15%	122
2024 Q1	$1.25B	Sell	23,002,360 -1,005,958	-4%	-$51.2M	0.22%	82
2023 Q4	$1.23B	Sell	24,008,318 -1,284,393	-5%	-$67.4M	0.22%	83
2023 Q3	$1.47B	Buy	25,292,711 +1,394,158	+6%	+$85.4M	0.28%	59
2023 Q2	$1.53B	Sell	23,898,553 -780,669	-3%	-$52.3M	0.29%	59
2023 Q1	$1.71B	Sell	24,679,222 -111,541	-0.4%	-$7.87M	0.34%	50
2022 Q4	$1.78B	Sell	24,790,763 -4,579	-0%	-$345K	0.37%	46
2022 Q3	$1.76B	Buy	24,795,342 +245,312	+1%	+$17.8M	0.4%	42
2022 Q2	$1.89B	Buy	24,550,030 +463,344	+2%	+$35.3M	0.4%	42
2022 Q1	$1.76B	Sell	24,086,686 -447,222	-2%	-$30M	0.31%	59
2021 Q4	$1.53B	Sell	24,533,908 -459,260	-2%	-$26.9M	0.25%	74
2021 Q3	$1.48B	Sell	24,993,168 -2,069,677	-8%	-$136M	0.26%	71
2021 Q2	$1.81B	Sell	27,062,845 -818,570	-3%	-$53.4M	0.32%	61
2021 Q1	$1.76B	Sell	27,881,415 -540,596	-2%	-$33.6M	0.33%	60
2020 Q4	$1.76B	Sell	28,422,011 -631,360	-2%	-$38.8M	0.34%	56
2020 Q3	$1.75B	Sell	29,053,371 -948,647	-3%	-$57.1M	0.38%	53
2020 Q2	$1.76B	Sell	30,002,018 -881,724	-3%	-$52.7M	0.42%	46
2020 Q1	$1.72B	Sell	30,883,742 -422,644	-1%	-$25.8M	0.49%	39
2019 Q4	$2.01B	Buy	31,306,386 +7,523,242	+32%	+$431M	0.45%	37
2019 Q3	$1.21B	Buy	23,783,144 +1,200,199	+5%	+$56.4M	0.29%	67
2019 Q2	$1.02B	Buy	22,582,945 +43,908	+0.2%	+$2.05M	0.24%	80
2019 Q1	$1.08B	Sell	22,539,037 -37,847	-0.2%	-$1.89M	0.27%	74
2018 Q4	$1.17B	Buy	22,576,884 +954,877	+4%	+$51.3M	0.33%	56
2018 Q3	$1.34B	Sell	21,622,007 -427,054	-2%	-$25.3M	0.33%	56
2018 Q2	$1.22B	Sell	22,049,061 -846,178	-4%	-$45.7M	0.31%	61
2018 Q1	$1.45B	Sell	22,895,239 -1,316,122	-5%	-$84.7M	0.38%	48
2017 Q4	$1.48B	Sell	24,211,361 -414,028	-2%	-$25.9M	0.38%	48
2017 Q3	$1.57B	Buy	24,625,389 +583,527	+2%	+$34.1M	0.41%	46
2017 Q2	$1.34B	Buy	24,041,862 +910,496	+4%	+$49.5M	0.37%	46
2017 Q1	$1.26B	Buy	23,131,366 +1,124,197	+5%	+$61.7M	0.36%	47
2016 Q4	$1.29B	Sell	22,007,169 -519,369	-2%	-$28.4M	0.39%	44
2016 Q3	$1.21B	Sell	22,526,538 -196,475	-0.9%	-$12.6M	0.38%	51
2016 Q2	$1.67B	Sell	22,723,013 -120,011	-0.5%	-$8.48M	0.54%	32
2016 Q1	$1.45B	Sell	22,843,024 -414,535	-2%	-$26.1M	0.48%	41
2015 Q4	$1.6B	Sell	23,257,559 -1,092,351	-4%	-$72.2M	0.53%	32
2015 Q3	$1.44B	Sell	24,349,910 -446,310	-2%	-$28.3M	0.48%	38
2015 Q2	$1.65B	Buy	24,796,220 +127,501	+0.5%	+$8.4M	0.5%	35
2015 Q1	$1.59B	Sell	24,668,719 -363,583	-1%	-$22.8M	0.48%	38
2014 Q4	$1.48B	Buy	25,032,302 +695,378	+3%	+$39.2M	0.45%	43
2014 Q3	$1.25B	Sell	24,336,924 -291,869	-1%	-$14.6M	0.39%	48
2014 Q2	$1.19B	Sell	24,628,793 -23,935	-0.1%	-$1.18M	0.37%	50
2014 Q1	$1.28B	Sell	24,652,728 -1,084,187	-4%	-$57.7M	0.4%	46
2013 Q4	$1.37B	Sell	25,736,915 -451,297	-2%	-$23M	0.44%	41
2013 Q3	$1.21B	Sell	26,188,212 -1,086,765	-4%	-$47.7M	0.43%	42
2013 Q2	$1.22B	Buy	+27,274,977	New	+$1.18B	0.44%	39

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust's BMY Position: Q1 2026 in Review

Northern Trust increased its Bristol-Myers Squibb (BMY) stake by 0.67% in Q1 2026, buying an estimated $9.54M and bringing the position to 24,758,771 shares worth $1.5B. The position accounts for 0.2% of the portfolio, ranked #90.

Northern Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.01B in Q4 2019. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Northern Trust held 24,758,771 shares of Bristol-Myers Squibb worth $1.5B as of Q1 2026.
Northern Trust bought 163,677 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.54M.
Bristol-Myers Squibb made up 0.2% of Northern Trust's portfolio in Q1 2026, its #90 holding.
Northern Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Northern Trust's Bristol-Myers Squibb position peaked at $2.01B in Q4 2019.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.